{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:35:23Z","timestamp":1767836123536,"version":"3.49.0"},"reference-count":25,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>The identification of autoantibodies associated with autoimmune liver disease (ALD) is crucial for diagnosis and management. Various laboratory methods have been introduced to detect autoantibody profiles. However, the variable performance of these assays may create challenges for clinicians and patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To investigate the concordance rates and diagnostic performance of 2 commercially available assays, line immunoassay (LIA) and digital liquid chip method (DLCM), in patients with ALD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>A total of 291 serum samples were collected, consisting of 180 sera from patients with ALD and 111 sera from controls. The samples were detected through LIA and DLCM. The agreement and diagnostic performance of each assay were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>There was substantial to almost perfect agreement among prevalent autoantibodies (anti\u2013mitochondrial antibody M2; antibodies against gp210, Sp100, and Ro52). Nevertheless, the Cohen \u03ba coefficient of some uncommon autoantibodies (anti\u2013LKM-1, anti\u2013LC-1, and anti-SLA\/LP) between the 2 methods was not ideal. LIA showed slightly better sensitivity, accuracy, and negative predictive value, while DLCM exhibited slightly higher specificity and positive predictive value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>LIA and DLCM demonstrated comparable performance for the detection of common ALD-related autoantibodies. LIA seemed to be more sensitive, while DLCM displayed more specificity. However, standardization of ALD autoantibody detection still faces challenges between these diverse detection systems. Comprehensive interlaboratory validation is essential to mitigate potential misunderstanding and confusion among patients and clinicians.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2024-0057-oa","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T20:01:16Z","timestamp":1717444876000},"page":"271-275","source":"Crossref","is-referenced-by-count":2,"title":["Clinical Performance of the Line Immunoassay and Digital Liquid Chip Method for Detecting Autoimmune Liver Disease Autoantibodies"],"prefix":"10.5858","volume":"149","author":[{"given":"Heye","family":"Lv","sequence":"first","affiliation":[{"name":"From the Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, China (Lv, Su)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ao","family":"Deng","sequence":"additional","affiliation":[{"name":"the Department of Laboratory Medicine, West China Tianfu Hospital of Sichuan University, Chengdu, China (Deng, Chen)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijun","family":"Chen","sequence":"additional","affiliation":[{"name":"the Department of Laboratory Medicine, West China Tianfu Hospital of Sichuan University, Chengdu, China (Deng, Chen)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenzhen","family":"Su","sequence":"additional","affiliation":[{"name":"From the Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, China (Lv, Su)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","published-online":{"date-parts":[[2024,6,4]]},"reference":[{"issue":"1","key":"2025022423520464900_i1543-2165-149-3-271-b01","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jhep.2013.09.020","article-title":"Autoimmune liver disease, autoimmunity and liver transplantation","volume":"60","author":"Carbone","year":"2014","journal-title":"J Hepatol"},{"issue":"6","key":"2025022423520464900_i1543-2165-149-3-271-b02","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1053\/j.gastro.2021.07.046","article-title":"Defining primary sclerosing cholangitis: results from an international primary sclerosing cholangitis study group consensus process","volume":"161","author":"Ponsioen","year":"2021","journal-title":"Gastroenterology"},{"key":"2025022423520464900_i1543-2165-149-3-271-b03","doi-asserted-by":"crossref","first-page":"e070201","DOI":"10.1136\/bmj-2022-070201","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"380","author":"Muratori","year":"2023","journal-title":"BMJ"},{"issue":"1","key":"2025022423520464900_i1543-2165-149-3-271-b04","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"2025022423520464900_i1543-2165-149-3-271-b05","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"issue":"10","key":"2025022423520464900_i1543-2165-149-3-271-b06","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/jgh.14746","article-title":"Systematic review and meta-analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American population","volume":"34","author":"Lv","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"2025022423520464900_i1543-2165-149-3-271-b07","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.cgh.2018.11.028","article-title":"Association between black race and presentation and liver-related outcomes of patients with autoimmune hepatitis","volume":"17","author":"de Boer","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"2025022423520464900_i1543-2165-149-3-271-b08","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-021-10276-6","article-title":"APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis","volume":"16","author":"You","year":"2022","journal-title":"Hepatol Int"},{"issue":"6","key":"2025022423520464900_i1543-2165-149-3-271-b09","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/jgh.15329","article-title":"Regional variation and temporal trend of primary biliary cholangitis epidemiology: a systematic review and meta-analysis","volume":"36","author":"Lv","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"2025022423520464900_i1543-2165-149-3-271-b10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cld.2022.06.007","article-title":"The inconvenient truth of primary biliary cholangitis\/autoimmune hepatitis overlap syndrome","volume":"26","author":"Hussain","year":"2022","journal-title":"Clin Liver Dis"},{"issue":"1","key":"2025022423520464900_i1543-2165-149-3-271-b11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American Association for the Study of Liver Diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"2025022423520464900_i1543-2165-149-3-271-b12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41423-020-00568-6","article-title":"Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease","volume":"18","author":"Horst","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"2025022423520464900_i1543-2165-149-3-271-b13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.autrev.2018.10.004","article-title":"Autoantibodies in idiopathic inflammatory myopathies: clinical associations and laboratory evaluation by mono- and multispecific immunoassays","volume":"18","author":"Damoiseaux","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"1","key":"2025022423520464900_i1543-2165-149-3-271-b14","first-page":"73","article-title":"Determination of specific autoantibodies in patients with systemic lupus erythematosus by line immunoassay, ELISA and CLIF assay","volume":"41","author":"Wongjarit","year":"2023","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"4","key":"2025022423520464900_i1543-2165-149-3-271-b15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/jcla.21522","article-title":"Comparative study of immunofluorescent antinuclear antibody test and line immunoassay detecting 15 specific autoantibodies in patients with systemic rheumatic disease","volume":"26","author":"Lee","year":"2012","journal-title":"J Clin Lab Anal"},{"issue":"5","key":"2025022423520464900_i1543-2165-149-3-271-b16","doi-asserted-by":"crossref","first-page":"556","DOI":"10.5858\/arpa.2022-0331-OA","article-title":"Clinical performance of the line immunoassay, digital liquid chip method, and chemiluminescent immunoassay for detecting specific antinuclear antibodies","volume":"148","author":"Su","year":"2024","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"2025022423520464900_i1543-2165-149-3-271-b17","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouill\u00e8res","year":"1998","journal-title":"Hepatology"},{"issue":"2","key":"2025022423520464900_i1543-2165-149-3-271-b18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.atherosclerosis.2006.11.036","article-title":"Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: a systematic review","volume":"194","author":"Sorokin","year":"2007","journal-title":"Atherosclerosis"},{"issue":"3","key":"2025022423520464900_i1543-2165-149-3-271-b19","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s12016-010-8234-y","article-title":"Overcoming a \u201cprobable\u201d diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature","volume":"42","author":"Bizzaro","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"issue":"11-12","key":"2025022423520464900_i1543-2165-149-3-271-b20","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/j.1365-2036.2006.03172.x","article-title":"Antinuclear antibodies giving the \u2018multiple nuclear dots\u2019 or the \u2018rimlike\/membranous\u2019 patterns: diagnostic accuracy for primary biliary cirrhosis","volume":"24","author":"Granito","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"2025022423520464900_i1543-2165-149-3-271-b21","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/liv.12658","article-title":"Anti-SLA\/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis","volume":"35","author":"Zachou","year":"2015","journal-title":"Liver Int"},{"key":"2025022423520464900_i1543-2165-149-3-271-b22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2013.08.001","article-title":"Clinical significance of autoantibodies in autoimmune hepatitis","volume":"46","author":"Liberal","year":"2013","journal-title":"J Autoimmun"},{"issue":"21","key":"2025022423520464900_i1543-2165-149-3-271-b23","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3748\/wjg.14.3374","article-title":"Autoimmune liver serology: current diagnostic and clinical challenges","volume":"14","author":"Bogdanos","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"6","key":"2025022423520464900_i1543-2165-149-3-271-b24","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hep.1840080632","article-title":"Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2","volume":"8","author":"Martini","year":"1988","journal-title":"Hepatology"},{"issue":"8528","key":"2025022423520464900_i1543-2165-149-3-271-b25","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(87)92024-1","article-title":"Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen","volume":"1","author":"Manns","year":"1987","journal-title":"Lancet"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/149\/3\/271\/3489408\/i1543-2165-149-3-271.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/149\/3\/271\/3489408\/i1543-2165-149-3-271.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:41:46Z","timestamp":1764790906000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/149\/3\/article-p271.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,6,4]]},"published-print":{"date-parts":[[2025,3,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2024-0057-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,4]]}}}